An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention
暂无分享,去创建一个
Francesca Cordero | Raffaele Calogero | Pierluigi Lollini | Federica Cavallo | Annalisa Astolfi | Manuela Iezzi | Guido Forni | P. Lollini | G. Forni | M. Iezzi | F. Cordero | R. Calogero | A. Astolfi | F. Cavallo
[1] S. Hedjazifar,et al. c-erbB2-induced disruption of matrix adhesion and morphogenesis reveals a novel role for protein kinase B as a negative regulator of alpha(2)beta(1) integrin function. , 2002, Molecular biology of the cell.
[2] Piero Musiani,et al. Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity , 2005, Clinical Cancer Research.
[3] M J O'Hare,et al. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. , 2001, Cancer immunity.
[4] Thomas K. Hoffmann,et al. Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells , 2001, The Journal of experimental medicine.
[5] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[6] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[7] P. Musiani,et al. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[8] Piero Musiani,et al. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. , 2004, The Journal of clinical investigation.
[9] Piero Musiani,et al. Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. , 2003, The Journal of clinical investigation.
[10] R. Xu,et al. Amplification of Her-2/neu Gene in Her-2/neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival Material , 2002, Modern Pathology.
[11] Piero Musiani,et al. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. , 2004, Cancer research.
[12] M. Brattain,et al. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. , 1997, Biochemical and biophysical research communications.
[13] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] O. Jänne,et al. Coregulator Small Nuclear RING Finger Protein (SNURF) Enhances Sp1- and Steroid Receptor-mediated Transcription by Different Mechanisms* , 2000, The Journal of Biological Chemistry.
[15] Hiroaki Nagano,et al. Expression of Uridine Diphosphate N-Acetyl-α-D-Galactosamine: Polypeptide N-Acetylgalactosaminyl Transferase 3 in Adenocarcinoma of the Pancreas , 2003, Pathobiology.
[16] Piero Musiani,et al. Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario , 2005, Cancer Immunology, Immunotherapy.
[17] Doron Lancet,et al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification , 2005, Bioinform..
[18] G. Viglietto,et al. RNF4 is a growth inhibitor expressed in germ cells but not in human testicular tumors. , 2001, The American journal of pathology.
[19] Thierry Boon,et al. Tumor‐specific shared antigenic peptides recognized by human T cells , 2002, Immunological reviews.
[20] O. Finn,et al. Premalignant Lesions as Targets for Cancer Vaccines , 2003, The Journal of experimental medicine.
[21] Saija Savolainen,et al. Small nuclear RING finger protein expression during gonad development: regulation by gonadotropins and estrogen in the postnatal ovary. , 2004, Endocrinology.
[22] Vishva M. Dixit,et al. RAIDD is a new 'death' adaptor molecule , 1997, Nature.
[23] Guido Forni,et al. Antitumor vaccines: is it possible to prevent a tumor? , 2002, Cancer Immunology, Immunotherapy.
[24] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.
[25] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[26] George A Calin,et al. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] Piero Musiani,et al. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. , 2005, The American journal of pathology.
[28] S. Srinivasula,et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. , 1997, Cancer research.
[29] Bernhard Horsthemke,et al. The RING Finger Protein RNF4, a Co-regulator of Transcription, Interacts with the TRPS1 Transcription Factor* , 2003, Journal of Biological Chemistry.
[30] Tatiana A. Tatusova,et al. Entrez Gene: gene-centered information at NCBI , 2004, Nucleic Acids Res..
[31] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[32] M J Bissell,et al. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. , 1998, The American journal of pathology.
[33] Sara A Byron,et al. Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer. , 2003, Seminars in oncology.
[34] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[35] K. Huebner,et al. Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer. , 2003, Genomics.
[36] Kenichi Matsuo,et al. Expression of UDP-N-Acetyl-α-d-Galactosamine-Polypeptide N-Acetylgalactosaminyltransferase Isozyme 3 in the Subserosal Layer Correlates with Postsurgical Survival of Pathological Tumor Stage 2 Carcinoma of the Gallbladder , 2004, Clinical Cancer Research.
[37] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Ostrand-Rosenberg,et al. Animal models of tumor immunity, immunotherapy and cancer vaccines. , 2004, Current opinion in immunology.
[39] Makoto Asada,et al. Aberrant expression of integrin and erbB subunits in breast cancer cell lines. , 2002, International journal of oncology.
[40] John Quackenbush,et al. Open source software for the analysis of microarray data. , 2003, BioTechniques.
[41] O. Finn,et al. Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.
[42] P. Musiani,et al. Immunoprevention of cancer: is the time ripe? , 2000, Cancer research.